PortfolioPortfolio mode

AMGN

Amgenstock

$447.380.62% today

Trade AMGN

← Research only mode

Research AMGN

AMGN · 90-day price history

Market cap

$237.3B

P/E

27.3

Div yield

2.30%

Industry

Drug Manufacturers - General

Exchange

NasdaqGS

Website ↗

Prediction models

All predictions →

Trend follower

Horizon: 1 week

Signal strength0.56

Historical accuracy53%

99 predictions · 12mBaseline 52%

How this works

Compares a 10-day vs 50-day moving average. When the short-term average rises above the long-term average, the trend is up.

Not financial advice. Past accuracy does not guarantee future results.

Momentum

Horizon: 1 week

Signal strength0.11

Historical accuracy30%

99 predictions · 12mBaseline 52%

How this works

Uses RSI (a gauge of recent buying/selling intensity) and 5-day rate-of-change to judge whether the stock has been pushed too far in one direction.

Not financial advice. Past accuracy does not guarantee future results.

Statistical trend

Horizon: 1 month

flat

Signal strength0.01

Historical accuracy41%

83 predictions · 12mBaseline 51%

How this works

Fits a trend line through the last 60 days of prices and measures how far the current price has strayed from it.

Not financial advice. Past accuracy does not guarantee future results.

Multi-factor + news

Horizon: 1 week

AI + NEWS

Signal strength0.31

Historical accuracy30%

37 predictions · 12mBaseline 52%

Accuracy reflects technical signals only. News sentiment is live.

How this works

Combines trend (25%), momentum (25%), volume (15%), and AI-analysed news sentiment (35%) from your trusted sources into one score.

Not financial advice. Past accuracy does not guarantee future results.

Bull / Bear thesis

AI analysis

Bull case●

Board appointment signals stable governance

Adding experienced director to audit committee

Company news

Large-cap biotech provides stability

Established pipeline of approved drugs

Price action

1.22% gain shows steady confidence

Positive momentum

Price action

Bear case●

Limited recent catalysts visible

No major news in past two weeks

Price action

Valuation at elevated levels

Stock at $445 reflects high multiples

Price action

Biosimilar competition pressuring pricing

Genetic drugs facing significant competition

Price action

AI-generated from recent news and price action. Not financial advice. Educational only.

Seasonality

~5y of history

Avg return by month · %

This month historically: +3.16% on average, up 40% of 5 years.

Avg return by weekday · %

Historical pattern only — seasonality is not a prediction and often breaks.

Recent news

No recent news found for AMGN.

AI research companion

AI Research Companion

Loading…